Award-winning reporter Erika Hayasaki tells an inspiring story of human suffering and scientific triumph. She talks to people with genetic abnormalities that skew their responses to pain. Their lives are difficult, but their contribution to science has been great. She profiles the various teams around the world researching medications that will target the pain gene. With all this competition, it’s just a matter of time before one of them finds a viable solution. getAbstract recommends Hayasaki’s article to anyone who would like a safe alternative to conventional painkillers.
In this summary, you will learn
- How pain works,
- What genetic conditions that make people more or less sensitive to pain can teach scientists about pain, and
- How the next generation of painkillers could be different.
About the Author
Erika Hayasaki is an associate professor of literary journalism at the University of California, Irvine and author of The Death Class: A True Story About Life.
Get the key points from this article in 10 minutes.
For your company
We help you build a culture of continuous learning.
Comment on this summary
Customers who read this summary also read
Esmé E. Deprez and Paul Barrett
Bloomberg Businessweek , 2017